T
Teruhiko Mizumoto
Publications - 1
Citations - 206
Teruhiko Mizumoto is an academic researcher. The author has contributed to research in topics: Renal function & Placebo. The author has an hindex of 1, co-authored 1 publications receiving 125 citations.
Papers
More filters
Journal ArticleDOI
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura,Tatsuo Hosoya,Shunya Uchida,Masaaki Inaba,Hirofumi Makino,Shoichi Maruyama,Sadayoshi Ito,Tetsuya Yamamoto,Yasuhiko Tomino,Iwao Ohno,Yugo Shibagaki,Satoshi Iimuro,Naohiko Imai,Masanari Kuwabara,Hiroshi Hayakawa,Hiroshi Ohtsu,Yasuo Ohashi,Seiichi Matsuo,Hisashi Yamanaka,Tadao Akizawa,Tamio Teramoto,Hiroshi Kasanuki,Kenichi Yoshimura,Hiroshi Sato,Satoshi Horikoshi,Syoichi Maruyama,Masahiko Inaba,Yuji Moriwaki,Haruhito Uchida,Nagayuki Kaneshiro,Hidekazu Moriya,Yasuhiro Komatsu,Shinya Kaname,Kazunari Hanaoka,Makoto Ogura,Masato Ikeda,Kenji Kasai,Akira Sugiura,Kazushi Takahashi,Kenichiro Kojima,Kosaku Nitta,Hirofumi Tamai,Hiroshi Nagaya,Senji Okuno,Ryusuke Kakiya,Hiroya Takeoka,Kyouji Hirata,Kenichiro Asano,Yasuo Fukaya,Yasushi Iwaida,Yasuo Tsuneda,Shigeaki Nishimura,Takeyuki Hiramatsu,Yoshitaka Isaka,Takafumi Ito,Yukio Yuzawa,Kunihiro Yamagata,Tadashi Sofue,Yoshimi Jinguji,Keita Hirano,Kazuhiro Matsuyama,Teruhiko Mizumoto,Yuko Shibuya,Masahiro Sugawara,Moritoshi Kadomura,Yasuaki Teshima,Hiroshi Ohtani,Hiroki Kamata,Susumu Okawara,Masaki Fukushima,Katsumi Takemura,Eriko Kinugasa,Masami Kogure,Yoichi Ehara +73 more
TL;DR: Compared to placebo, febuxostat did not mitigate the decline in kidney function among patients with stage 3 CKD and asymptomatic hyperuricemia andSubgroup analysis demonstrated a significant benefit from febUXostat in patients without proteinuria and for whom serum creatinine concentration was lower than the median.